Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Deruelle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2005
[Idiopathic acute partial renal infarction]Vincent Joulin, Federico Sallusto, Charles Deruelle, et al.
Urologic Oncology|June 30, 2023
Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRITruong-An Nguyen, Alexandre Fourcade, Audrey Zambon, et al.
Clinical Genitourinary Cancer|February 28, 2025
Incidence of Significant Prostate Cancer in the Follow-Up of Patients With Suspicious Lesion on MRI and Negative Targeted and systematic BiopsiesClaire Siebert, Truong-An Nguyen, Alexandre Fourcade, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2020
First-in-human use of a marine oxygen carrier (M101) for organ preservation: A safety and proof-of-principle studyYannick Le Meur, Lionel Badet, Marie Essig, et al.
Clinical Genitourinary Cancer|February 26, 2022
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate CancerKevin Saout, Audrey Zambon, Truong An Nguyen, et al.
Scandinavian Journal of Urology|February 22, 2018
The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancerAlexandre Fourcade, Charlotte Payrard, Valentin Tissot, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 13, 2005
[Idiopathic acute partial renal infarction]Vincent Joulin, Federico Sallusto, Charles Deruelle, et al.
Urologic Oncology|June 30, 2023
Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRITruong-An Nguyen, Alexandre Fourcade, Audrey Zambon, et al.
Clinical Genitourinary Cancer|February 28, 2025
Incidence of Significant Prostate Cancer in the Follow-Up of Patients With Suspicious Lesion on MRI and Negative Targeted and systematic BiopsiesClaire Siebert, Truong-An Nguyen, Alexandre Fourcade, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2020
First-in-human use of a marine oxygen carrier (M101) for organ preservation: A safety and proof-of-principle studyYannick Le Meur, Lionel Badet, Marie Essig, et al.
Clinical Genitourinary Cancer|February 26, 2022
Impact of Multiparametric MRI and PSA Density on the Initial Indication or the Maintaining in Active Surveillance During Follow-Up in low-Risk Prostate CancerKevin Saout, Audrey Zambon, Truong An Nguyen, et al.
Scandinavian Journal of Urology|February 22, 2018
The combination of targeted and systematic prostate biopsies is the best protocol for the detection of clinically significant prostate cancerAlexandre Fourcade, Charlotte Payrard, Valentin Tissot, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
Pageof 1